Rapamycin Reverses the Hepatic Response to Diet‐Induced Metabolic Stress That Is Amplified by Aging
Aging Cell · 2026
DOI: 10.1111/acel.70395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Aaron Havas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA. Hauptthemen laut MEDLINE: Sirolimus, Aging, Liver, Diet, High-Fat. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Society of Hematology, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Aging is associated with increased susceptibility to metabolic stress and chronic liver disease, yet the interactions between age and metabolic stressors and the potential for ameliorating interventions remain incompletely understood. Here, we examined the hepatic response of young (7‐month‐old) and old (25‐month‐old) C57BL/6 male mice to a 9‐week high‐fat diet (HFD) and assessed whether rapamycin, a well‐established pro‐longevity intervention, could mitigate age‐exacerbated effects. While both age groups developed metabolic‐associated steatohepatitis (MASH), older mice displayed more severe hepatic steatosis, inflammation, and transcriptional dysregulation. Transcriptomic profiling of whole livers and purified hepatocytes revealed that aging amplifies HFD‐induced inflammatory and metabolic gene expression changes, including activation of immune pathways and suppression of metabolic pathways. Notably, treatment of aging mice with rapamycin reversed the majority of HFD‐driven transcriptional alterations, including upregulation of pro‐inflammatory regulators such as Stat1, and dysregulation of metabolic gene networks. Rapamycin also reduced hepatosteatosis, total body weight, and a tumorigenic transcriptomic signature associated with hepatocellular carcinoma risk. These findings demonstrate that aging intensifies hepatic sensitivity to dietary metabolic stress and identify rapamycin as a promising therapeutic to counteract age‐related liver dysfunction and metabolic dysfunction‐associated steatotic liver disease (MASLD) progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
- University of California San Diego, La Jolla, California, USA.
ORCID-Profile: Armin Gandhi, Peter D Adams
Förderung
- American Society of Hematology
- NIA NIH HHS
- NCI NIH HHS
- National Institute of Aging
- National Cancer Institute
Zitieren
APA
Havas, A., Rajesh, A., Lei, X., Proulx, J., Miller, K. N., Field, A., Davis, A., Teneche, M. G., Gandhi, A., Lee, J., Feng, G. S., & Adams, P. D. (2026). Rapamycin Reverses the Hepatic Response to Diet‐Induced Metabolic Stress That Is Amplified by Aging. Aging Cell. https://doi.org/10.1111/acel.70395
Vancouver
Havas A, Rajesh A, Lei X, Proulx J, Miller KN, Field A, et al. Rapamycin Reverses the Hepatic Response to Diet‐Induced Metabolic Stress That Is Amplified by Aging. Aging Cell. 2026. doi:10.1111/acel.70395
BibTeX
@article{Havas2026,
author = {Havas, Aaron and Rajesh, Adarsh and Lei, Xue and Proulx, Jessica and Miller, Karl N and Field, Adam and Davis, Andrew and Teneche, Marcos Garcia and Gandhi, Armin and Lee, Jin and Feng, Gen-Sheng and Adams, Peter D},
title = {Rapamycin Reverses the Hepatic Response to Diet‐Induced Metabolic Stress That Is Amplified by Aging},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70395}
}
EUVIMED